At a gene therapy conference, there was excitement about the first correction of a genetic misspelling, along with questions ...

How likely is it for President Trump's new drug-pricing plan to be implemented? And will we see a return of Elizabeth Holmes' blood-testing ambitions? All that and more on "The Readout LOUD" podcast.

Research leaders voiced concerns about attacks on diversity efforts, grant terminations, and fear among scientists at #STATBreakthrough.

Elizabeth Holmes had more resources, talent, and opportunity than most founders will ever see — and she blew it. Now, writes ...

In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized ...

A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...

Republicans on the House Appropriations Committee lauded the Make America Healthy Again movement on Wednesday while pushing ...

Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues, experts ...

CMS and ASTP, the health department’s health IT regulator, released a request for information this week about existing ...

Good morning! Despite believing that headlines on STAT stories are “terrible,” former FDA head Robert Califf said at ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.